Methodology
Phase I
First clinical trial phase: safety in humans.
Phase I trials evaluate safety, tolerability, PK, and PD in healthy volunteers (20-100 subjects) or patients for oncology. Duration: months.
Methodology
First clinical trial phase: safety in humans.
Phase I trials evaluate safety, tolerability, PK, and PD in healthy volunteers (20-100 subjects) or patients for oncology. Duration: months.